The stock continues to trade defensively with an analyst downgrade.
Shares of online learning company don't look like a smart bet here.
LLY is looking shaky, despite fundamental improvements from its weight-loss drug tirzepatide.
The shares of this utility stock have turned lower from a choppy sideways pattern.
Shares of the :Portland-based apparel maker have been in a downward trend the past 12 months.
Counting on analysts to warn you to take profits at the top, or load up when valuations are low, is a fool's game.
The decline accelerated in January and has not hit bottom.
The shares are trying to hold above the March nadir.
The shares are plunging and the charts aren't coming to the rescue.
A bearish divergence can sometimes foreshadow a correction.